Chinese Investors to Build Pharma Factory in the Russian Far East

| By | Dietary Supplements, Russian Pharma

The largest pharmaceutical factory in the Russian Far East may be constructed by the Chinese Harbin Pharmaceutical Co. in the Amur Region. According to press service of the Amur region’s government, plant’s expected annual income may reach up to 1.6 billion yuan.

“The Amur region is attractive to us because of the great potential of electricity, the necessary volume of raw materials, primarily soybean and corn, and preferential conditions for investors,” said the head of the Chinese company.

For the production of dietary supplements and medicines, the plant is ready to purchase up to 126 thousand tons of Amur corn and 6.800 tons of soybean oil a year. The investor wants to sell the end product to Asian countries.

The new factory will employ more than 1.500 people. The regional government noted: in the Amur region there is a necessary educational base for future employees. The plant’s management is ready to hire local medical staff after necessary training, the governor’s press service reports.

Investors are planning to become part of the local territory of priority development – the construction site will be selected by the Investment Promotion Agency of the Amur Region.

Following the negotiations, the parties will work on the implementation of the project, including the requirements of environmental legislation.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.